Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

International Journal of Cancer

Volumn 137, Issue 8, 2015, Pages 1870-1878

  Mancikova, Veronika ^a   Cruz, Raquel ^b   Inglada Pérez, Lucía ^a,c   Fernández Rozadilla, Ceres ^b,d   Landa, Iñigo ^e   Cameselle Teijeiro, José ^f   Celeiro, Catuxa ^b   Pastor, Susana ^g   Velázquez, Antonia ^g   Marcos, Ricard ^g,h   Andía, Victor ⁱ   Álvarez Escolá, Cristina ^j   Meoro, Amparo ^k   Schiavi, Francesca ^l   Opocher, Giuseppe ^l,m   Quintela, Inés ^f   Ansede Bermejo, Juan ^f   Ruiz Ponte, Clara ^b   Santisteban, Pilar ⁿ   Robledo, Mercedes ^a   Carracedo, Angel ^b   more..

^a Structural Biology and Biocomputing Programme   (Spain)

^b Genomic Medicine Group   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^l VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^m UNIVERSITY OF PADOVA   (Italy)

ⁿ INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

more..

Author keywords

FOXE1; genetic heterogeneity; HTR1B; susceptibility; thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHILD; CHROMOSOME 10Q; CHROMOSOME 6Q; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FORKHEAD BOX PROTEIN E1 GENE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN EUROPEAN; SPANIARD; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; CHROMOSOME 10; CHROMOSOME 6; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SPAIN; THYROID TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84938997018     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29557     Document Type: Article

References (42)

1. Czene K, Lichtenstein P, Hemminki K,. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-cancer database. Int J Cancer 2002; 99: 260-6.
2. Frich L, Glattre E, Akslen LA,. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev 2001; 10: 113-17.
3. Risch N,. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001; 10: 733-41.
4. Cavaco BM, Batista PF, Sobrinho LG, et al., Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 2008; 93: 4426-30.
5. He H, Nagy R, Liyanarachchi S, et al., A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 2009; 69: 625-31.
6. Malchoff CD, Sarfarazi M, Tendler B, et al., Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000; 85: 1758-64.
7. McKay JD, Lesueur F, Jonard L, et al., Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001; 69: 440-6.
8. Suh I, Filetti S, Vriens MR, et al., Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 2009; 146: 1073-80.
9. Landa I, Robledo M,. Association studies in thyroid cancer susceptibility: are we on the right track? J Mol Endocrinol 2011; 47: R43-R58.
10. Landa I, Boullosa C, Inglada-Perez L, et al., An epistatic interaction between the pax8 and STK17B genes in papillary thyroid cancer susceptibility. PLoS One 2013; 8: e74765
11. Wei WH, Hemani G, Haley CS,. Detecting epistasis in human complex traits. Nat Rev Genet 2014; 15: 722-33.
12. Bufalo NE, Leite JL, Guilhen AC, et al., Smoking and susceptibility to thyroid cancer: an inverse association with cyp1a1 allelic variants. Endocr Relat Cancer 2006; 13: 1185-93.
13. Bufalo NE, Santos RB, Cury AN, et al., Genetic polymorphisms associated with cigarette smoking and the risk of graves' disease. Clin Endocrinol (Oxf) 2008; 68: 982-7.
14. Ho T, Li G, Lu J, et al., Association of xrcc1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 2009; 19: 129-35.
15. Landa I, Montero-Conde C, Malanga D, et al., Allelic variant at -79 (C>T) in CDKN1B (p27kip1) confers an increased risk of thyroid cancer and alters mRNA levels. Endocr Relat Cancer 2010; 17: 317-28.
16. Landa I, Ruiz-Llorente S, Montero-Conde C, et al., The variant rs1867277 in foxe1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 2009; 5: e1000637.
17. Gudmundsson J, Sulem P, Gudbjartsson DF, et al., Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 2012; 44: 319-22.
18. Gudmundsson J, Sulem P, Gudbjartsson DF, et al., Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in european populations. Nat Genet 2009; 41: 460-4.
19. Kohler A, Chen B, Gemignani F, et al., Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab 2013; 98: E1674-E1681.
20. Takahashi M, Saenko VA, Rogounovitch TI, et al., The foxe1 locus is a major genetic determinant for radiation-related thyroid carcinoma in chernobyl. Hum Mol Genet 2010; 19: 2516-23.
21. Purcell S, Neale B, Todd-Brown K, et al., PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
22. Amigo J, Salas A, Costas J, et al., GDF: dealing with high-throughput genotyping multiplatform data for medical and population genetic applications. J Proteomics Bioinformatics 2012; 5: 1-6.
23. Akulevich NM, Saenko VA, Rogounovitch TI, et al., Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 2009; 16: 491-503.
24. Jones AM, Howarth KM, Martin L, et al., Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 2012; 49: 158-63.
25. Browning BL, Browning SR,. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009; 84: 210-23.
26. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
27. Wu MC, Lee S, Cai T, et al., Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011; 89: 82-93.
28. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al., Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1: e65
29. Figlioli G, Kohler A, Chen B, et al., Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. J Clin Endocrinol Metab 2014; 99: E2084-E2092.
30. Baran Y, Quintela I, Carracedo A, et al., Enhanced localization of genetic samples through linkage-disequilibrium correction. Am J Hum Genet 2013; 92: 882-94.
31. Hutter CM, Chang-Claude J, Slattery ML, et al., Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 2012; 72: 2036-44.
32. Vega A, Campos B, Bressac-De-Paillerets B, et al., The R71G brca1 is a founder spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 2001; 17: 520-1.
33. Stratton MR, Rahman N,. The emerging landscape of breast cancer susceptibility. Nat Genet 2008; 40: 17-22.
34. Milne RL, Burwinkel B, Michailidou K, et al., Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the breast cancer association consortium. Hum Mol Genet 2014; 23: 6096-111.
35. Chernova OB, Hunyadi A, Malaj E, et al., A novel member of the WD-repeat gene family, wdr11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells. Oncogene 2001; 20: 5378-92.
36. Henriksen R, Dizeyi N, Abrahamsson PA,. Expression of serotonin receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-ht4 in ovary and in ovarian tumours. Anticancer Res 2012; 32: 1361-6.
37. Kopparapu PK, Tinzl M, Anagnostaki L, et al., Expression and localization of serotonin receptors in human breast cancer. Anticancer Res 2013; 33: 363-70.
38. Takai D, Yagi Y, Wakazono K, et al., Silencing of HTR1B and reduced expression of edn1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 2001; 20: 7505-13.
39. Wentzensen N, Bakkum-Gamez JN, Killian JK, et al., Discovery and validation of methylation markers for endometrial cancer. Int J Cancer 2014; 135: 1860-8.
40. Leone AM, Errico M, Lin SL, et al., Activation of extracellular signal-regulated kinase (ERK) and akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by rgs4. J Neurochem 2000; 75: 934-8.
41. Nikiforov YE, Nikiforova MN,. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7: 569-80.
42. Zamani A, Qu Z,. Serotonin activates angiogenic phosphorylation signaling in human endothelial cells. FEBS Lett 2012; 586: 2360-5.